Covid-19 testing demand surges as cases spike across Asia
Phase Scientific has developed the world’s first urine-based human papillomavirus test, and is planning to expand that business globally
[BEIJING] Demand for Covid-19 tests is increasing in Hong Kong as cases surge in recent weeks, according to the top executive of diagnostic kit maker Phase Scientific International.
The Hong Kong-based company, which is a major provider of Covid-19 testing kits in Asia Pacific, has seen business gain because of the Covid-19 wave across Asia, chief executive officer Ricky Chiu said.
Health authorities in densely-populated Hong Kong and Singapore have warned that Covid-19 cases are spiking, while data from the Chinese Center for Disease Control and Prevention showed the Covid-19 wave in China is on track reach last year’s summer peak. Shares of Covid-19 test kit and drug makers in Asia have risen tracking a surge in infections.
“Covid-19 is a seasonal thing,” said Chiu, adding that “definitely there is a spike in the business”.
Phase Scientific has also seen growth in its non-Covid-19 testing business due to the pandemic, which made more people aware of the importance of at-home testing for other diseases, Chiu said.
The company has developed the world’s first urine-based human papillomavirus test, and is planning to expand that business globally.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
The company raised US$34 million in Series A financing this week, the largest such round in Asia’s diagnostic technology sector since 2019. BLOOMBERG
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
On the board but frozen out: The Taib family feud tearing Sarawak construction giant apart
Thai and Vietnamese farmers may stop planting rice because of the Iran war. Here’s why
From post-war hardships to ‘era of national rise’: Vietnam’s family firms face first succession test
‘We’re not a bubble tea brand’: Chagee aims to double Asia-Pacific footprint to 600 stores by 2027